These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19007108)

  • 1. Synthetic and crystallographic studies of a new inhibitor series targeting Bacillus anthracis dihydrofolate reductase.
    Beierlein JM; Frey KM; Bolstad DB; Pelphrey PM; Joska TM; Smith AE; Priestley ND; Wright DL; Anderson AC
    J Med Chem; 2008 Dec; 51(23):7532-40. PubMed ID: 19007108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.
    Joska TM; Anderson AC
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3435-43. PubMed ID: 17005826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The solution structure of Bacillus anthracis dihydrofolate reductase yields insight into the analysis of structure-activity relationships for novel inhibitors.
    Beierlein JM; Deshmukh L; Frey KM; Vinogradova O; Anderson AC
    Biochemistry; 2009 May; 48(19):4100-8. PubMed ID: 19323450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
    Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase.
    Bennett BC; Xu H; Simmerman RF; Lee RE; Dealwis CG
    J Med Chem; 2007 Sep; 50(18):4374-81. PubMed ID: 17696333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of aryl ether inhibitors of the Bacillus anthracis enoyl-ACP reductase.
    Tipparaju SK; Mulhearn DC; Klein GM; Chen Y; Tapadar S; Bishop MH; Yang S; Chen J; Ghassemi M; Santarsiero BD; Cook JL; Johlfs M; Mesecar AD; Johnson ME; Kozikowski AP
    ChemMedChem; 2008 Aug; 3(8):1250-68. PubMed ID: 18663709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase.
    Tipparaju SK; Joyasawal S; Forrester S; Mulhearn DC; Pegan S; Johnson ME; Mesecar AD; Kozikowski AP
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3565-9. PubMed ID: 18499454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of Bacillus anthracis dihydrofolate reductase with the dihydrophthalazine-based trimethoprim derivative RAB1 provides a structural explanation of potency and selectivity.
    Bourne CR; Bunce RA; Bourne PC; Berlin KD; Barrow EW; Barrow WW
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3065-73. PubMed ID: 19364848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim.
    Barrow EW; Bourne PC; Barrow WW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4643-9. PubMed ID: 15561838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships.
    Beierlein JM; Karri NG; Anderson AC
    J Med Chem; 2010 Oct; 53(20):7327-36. PubMed ID: 20882962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase.
    Bourne CR; Wakeham N; Nammalwar B; Tseitin V; Bourne PC; Barrow EW; Mylvaganam S; Ramnarayan K; Bunce RA; Berlin KD; Barrow WW
    Biochim Biophys Acta; 2013 Jan; 1834(1):46-52. PubMed ID: 22999981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.
    Li X; Hilgers M; Cunningham M; Chen Z; Trzoss M; Zhang J; Kohnen L; Lam T; Creighton C; G C K; Nelson K; Kwan B; Stidham M; Brown-Driver V; Shaw KJ; Finn J
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5171-6. PubMed ID: 21831637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysaccharide deacetylases serve as new targets for the design of inhibitors against Bacillus anthracis and Bacillus cereus.
    Balomenou S; Koutsioulis D; Tomatsidou A; Tzanodaskalaki M; Petratos K; Bouriotis V
    Bioorg Med Chem; 2018 Jul; 26(13):3845-3851. PubMed ID: 29983281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bacterial dihydrofolate reductase by 6-alkyl-2,4-diaminopyrimidines.
    Nammalwar B; Bourne CR; Bunce RA; Wakeham N; Bourne PC; Ramnarayan K; Mylvaganam S; Berlin KD; Barrow EW; Barrow WW
    ChemMedChem; 2012 Nov; 7(11):1974-82. PubMed ID: 22930550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of substituted 2,4-diaminopyrimidines that inhibit Bacillus anthracis.
    Nammalwar B; Bunce RA; Berlin KD; Bourne CR; Bourne PC; Barrow EW; Barrow WW
    Eur J Med Chem; 2012 Aug; 54():387-96. PubMed ID: 22703705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of inhibitors of thymidine monophosphate kinase from Bacillus anthracis.
    Byun Y; Vogel SR; Phipps AJ; Carnrot C; Eriksson S; Tiwari R; Tjarks W
    Nucleosides Nucleotides Nucleic Acids; 2008 Mar; 27(3):244-60. PubMed ID: 18260009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling toward selective inhibitors of dihydrofolate reductase from the biological warfare agent Bacillus anthracis.
    Giacoppo JO; Mancini DT; Guimarães AP; Gonçalves AS; da Cunha EF; França TC; Ramalho TC
    Eur J Med Chem; 2015 Feb; 91():63-71. PubMed ID: 24985033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis.
    Gustafsson TN; Osman H; Werngren J; Hoffner S; Engman L; Holmgren A
    Biochim Biophys Acta; 2016 Jun; 1860(6):1265-71. PubMed ID: 26971857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design.
    Bennett BC; Wan Q; Ahmad MF; Langan P; Dealwis CG
    J Struct Biol; 2009 May; 166(2):162-71. PubMed ID: 19374017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.